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Abstract: Two potential bioactive pyrimidine-5-carbonitrile derivatives have been synthesized and char-
acterized by spectroscopic techniques (1H and 13C-NMR) and the three dimensional structures were
elucidated by single crystal X-ray diffraction at low temperature (160 K). In both structures, the molec-
ular conformation is locked by an intramolecular C–H฀C interaction involving the cyano and CH of
the thiophene and phenyl rings. The intermolecular interactions were analyzed in a qualitative man-
ner based on the Hirshfeld surface and 2D-fingerprint plots. The results suggest that the phenyl and
thiophene moieties have an effect on the crystal packing. For instance, the chalcogen bonds are only
preferred in the thiophene derivative. However, both structures uses a common N–H฀O hydrogen bond
motif. Moreover, the structures of 1 and 2 display 1D isostructurality and molecular chains stabilize
by intermolecular N–H฀O and N–H฀N hydrogen bonds. The nature and extent of different non-covalent
interactions were further characterized by the topological parameters derived from the quantum the-
ory of atoms-in-molecules approach. This analysis indicates that apart from N–H฀O hydrogen bonds,
other non-covalent interactions are closed-shell in nature. A strong and linear N–H฀O hydrogen bond
shows intermediate bonding character between shared and closed-shell interactions. The molecular dock-
ing analysis suggests that both compounds display potential inhibitory effect against the dihydrofolate
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Quantitative analysis of hydrogen and chalcogen
bonds in two pyrimidine-5-carbonitrile derivatives,
potential DHFR inhibitors: an integrated
crystallographic and theoretical study†
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Mohamed Yehya Annavi Syed Majeed,b Olivier Blacque, c Aamal A. Al-Mutairi,d
Ali A. El-Emam,e M. Judith Percino f and Subbiah Thamotharan *b
Two potential bioactive pyrimidine-5-carbonitrile derivatives have been synthesized and characterized by
spectroscopic techniques (1H and 13C-NMR) and the three dimensional structures were elucidated by
single crystal X-ray diffraction at low temperature (160 K). In both structures, the molecular
conformation is locked by an intramolecular C–H/C interaction involving the cyano and CH of the
thiophene and phenyl rings. The intermolecular interactions were analyzed in a qualitative manner based
on the Hirshfeld surface and 2D-fingerprint plots. The results suggest that the phenyl and thiophene
moieties have an effect on the crystal packing. For instance, the chalcogen bonds are only preferred in
the thiophene derivative. However, both structures uses a common N–H/O hydrogen bond motif.
Moreover, the structures of 1 and 2 display 1D isostructurality and molecular chains stabilize by
intermolecular N–H/O and N–H/N hydrogen bonds. The nature and extent of different non-covalent
interactions were further characterized by the topological parameters derived from the quantum theory
of atoms-in-molecules approach. This analysis indicates that apart from N–H/O hydrogen bonds, other
non-covalent interactions are closed-shell in nature. A strong and linear N–H/O hydrogen bond shows
intermediate bonding character between shared and closed-shell interactions. The molecular docking
analysis suggests that both compounds display potential inhibitory effect against the dihydrofolate
reductase (DHFR) enzyme from humans and Staphylococcus aureus.
Introduction
Pyrimidine and its related derivatives have long been known as
efficient chemotherapeutic agents.1 The chemotherapeutic
potency of pyrimidine-based drugs is attributed to their inhib-
itory effect on the biosynthesis of vital enzymes responsible for
nucleic acids such as thymidylate synthetase (TSase), thymidine
phosphorylase (TPase), dihydrofolate reductase (DHFR) and
reverse transcriptase (RTase). Several pyrimidine-based drugs
are currently used as efficient anticancer2–6 and antiviral agents
against human immunodeciency viruses (HIV),7–10 hepatitis B
virus (HBV),11,12 herpes simplex virus (HSV)13 and SARS-CoV
virus.14 In addition, several pyrimidine-based drugs are
currently used as antibacterial agents. Trimethoprim was early
discovered as a potent drug mainly in the treatment of urinary
tract infections acting by inhibition of dihydrofolate reductase
(DHFR).15 The next generations of DHFR inhibitors including
brodimoprim,16 epiroprim17 and iclaprim18 were developed as
highly potent antibacterial drugs for the treatment of severe
respiratory tract infections. DHFR inhibitors bind bacterial
DHFR 105 times tighter than it does to vertebrate DHFR. By
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virtue of their mechanism of action, antibacterial DHFR
inhibitors exert their activity through blocking synthesis of
DNA, RNA and proteins, thereby arresting bacterial cell
growth.19,20 Pyrimidine-based DHFR inhibitors are also used as
potent antiprotozoal agents for the treatment of malaria,21,22
trypanosomiasis23 and leishmaniasis.24 It has been reported
that the barbituric acid, a pyrimidine heterocylic nucleus, was
used as a molecular recognition species by non-covalent inter-
actions especially hydrogen bonds or via coordination to metal
ions. Using this molecular recognition approach, different types
of receptors that belong to organic, inorganic and organome-
tallic have been developed for barbituric acid.25
In view of the diverse applications of the pyrimidine deriv-
atives, we have synthesized two pyrimidine-5-carbonitrile
derivatives and crystal structures of these compounds have
been studied in detail in the present investigation. The reported
compounds vary with respect to the thiophene and phenyl
substituents. A CSD (Cambridge Structural Database; CSD
Version 5.41, November 2019; update 1 March 2020) search26
was conducted using the compound 1 as a template in which
substituents at 2 and 4 positions kept ‘X’ (any) and this search
yielded 8 hits (csd refcodes: GAHTIS, ILEREY, MUTGOY,
MUTGUE, OKUWEY, SEDTAY, XAYLUF and ZAPQEO). In all
these structures, a strong and directional N–H/O hydrogen
bonded R2
2(8) synthon is formed between amino and carbonyl
groups of the pyrimidine ring except in 2-amino-4-(3,4-
dimethyoxyphenyl)-6-oxo-1,6-dihydropyrimidine-5-carbonitrile
N,N-dimethylformamide solvate (csd refcode: SEDTAY27). This
self-assembled R2
2(8) synthon was disrupted due to the pres-
ence of N,N-dimethylformamide solvate. However, the carbonyl
group of the solvate has participated in a N–H/O bond with
amino group of the pyrimidine moiety.
Among 8 hits, 3 structures (6-oxo-4-propyl-2-(propylthio)-1,6-
dihydropyrimidine-5-carbonitrile; csd refcode: ILEREY,28 2-[(4-
uorobenzyl)sulfanyl]-4-(2-methylpropyl)-6-oxo-1,6-dihydropyrim
idine-5-carbonitrile; csd refcode: OKUWEY29 and 2-[(2-
methoxyethyl)sulfanyl]-4-(2-methylpropyl)-6-oxo-1,6-dihydropyrimi
dine-5-carbonitrile; csd refcode: ZAPQEO30) were found to be
closely related structures to the title compounds. In these 3
structures, the S atom is present at the 2nd position of the pyrim-
idine ring. In addition to hydrogen bond donors and acceptors,
two chalcogen atoms (O and S) also present in these 3 structures
and in the title compounds. The chalcogen bond (ChB) is one of
the types of non-covalent interactions and has gained great interest
in studying the role of such a bond in different areas including
crystal engineering, materials science and biological sciences etc.
The chalcogen bond is dened as R–Ch/A, where Ch is the
chalcogen bond donor (electron-poor) and A is the chalcogen bond
acceptor (electron-rich).31 The lone pair carbonyl and p system
could act as chalcogen acceptors in the title compounds and their
closely related structures. Therefore, a detailed investigation has
been performed to study the nature and strength of chalcogen
bond in the title compounds in addition to conserved and self-
assembled R2
2(8) synthon mediated by the N–H/O hydrogen
bond in pyrimidine-5-carbonitrile containing compounds.
To gain qualitative and quantitative insights into intra- and
intermolecular interactions, we performed different analyses,
including the Hirshfeld surface, 2D-ngerprint plots, energy
frameworks, PIXEL energy, and Bader's quantum theory of
atoms-in-molecules (QTAIM).32 The rst four criteria ((a)
topology, (b) electron density, (c) Laplacian of electron density
and (d) mutual penetration of the hydrogen and the acceptor
atom) of Koch–Popelier33 have been used to characterize the
nature and strength of non-covalent interactions as previously
reported.34,35 In addition, molecular docking study of the title




The pyrimidine-5-carbonitrile derivatives 1 and 2 were synthe-
sized starting with the appropriate aldehydes A via condensa-
tion with thiourea B and ethyl cyanoacetate C, in ethanol, in the
presence of anhydrous potassium to yield the intermediates 6-
(thiophen-2-yl)-2-thiouracil-5-carbonitrile D36 and 6-phenyl-2-
thiouracil-5-carbonitrile E,37 which were reacted with bromo-
ethane in the presence of potassium carbonate to yield the
target compounds 1 and 2 (Scheme 1).
Bromoethane (1.1 g m, 0.01 mol) and anhydrous potassium
carbonate (1.38 g, 0.01 mol) were added to a solution of the
appropriate 2-thiouracil-5-carbonitrile D or E (0.01 mol) in DMF
(10 mL) and the mixture was stirred at room temperature for 12
hours. Water (15 mL) was the added to the reaction with stirred
for further 30 minutes. The precipitated crude product was
ltered, washed with cold water, dried and crystallized from
aqueous ethanol. The pure single crystals of compounds 1 and 2
were obtained by slow evaporation of ethanolic solution at room
temperature.
2-Ethylsulfanyl-6-(thiophen-2-yl)-3,4-dihydro-4-
oxopyrimidine-5-carbonitrile (1). Yellow transparent block crys-
tals; yield 1.87 g m (71%); mp 282–284 C; mol. formula (mol wt):
C11H9N3OS2 (263.34).
1H NMR (DMSO-d6, 700.17 MHz): d 1.28 (t,
3H, CH3, J ¼ 7.4 Hz), 2.88 (q, 2H, CH2, J ¼ 7.4 Hz), 7.32 (t, 1H,
thiophene-H, J ¼ 4.0 Hz), 7.44–7.65 (m, 2H, thiophene-H), 12.90
(s, 1H, NH). 13C NMR (DMSO-d6, 176.08 MHz): d 12.08 (CH3),
25.88 (CH2), 98.28 (C-5), 114.98 (CN), 125.98, 127.50, 131.90,
136.80 (thiophene-C), 163.32 (C-2), 168.20 (C]O), 177.60 (C-6).
Scheme 1 The synthetic pathway for compounds 1 and 2.



























































































































FT-IR (in cm1) (NH: 3451, thiophene CH: 3028, aliphatic CH:
2841, CN: 2218, C]O: 1651, C]N: 1522).
2-Ethylsulfanyl-6-phenyl-3,4-dihydro-4-oxopyrimidine-5-
carbonitrile (2). Colorless transparent needle crystals; yield
2.03 g m (79%); mp 250–252 C; mol. formula (mol wt):
C13H11N3OS (257.30).
1H NMR (DMSO-d6, 700.17 MHz): d 1.29
(t, 3H, CH3, J ¼ 7.5 Hz), 2.92 (q, 2H, CH2, J ¼ 7.5 Hz), 7.12–7.24
(m, 3H, Ar–H), 7.39 (d, 2H, Ar–H, J ¼ 7.8 Hz), 13.22 (s, 1H, NH).
13C NMR (DMSO-d6, 176.08 MHz): d 13.22 (CH3), 24.80 (CH2),
95.70 (C-5), 115.0 (CN), 127.22, 129.50, 131.20, 136.74 (Ar–C),
162.98 (C-2), 168.40 (C]O), 177.54 (C-6). FT-IR (in cm1) (NH:
3450, aromatic CH: 3018, aliphatic CH: 2849, CN: 2219, C]O:
1657, C]N: 1534). The FT-IR spectra for compounds 1 and 2 are
given in the ESI.†
Single crystal X-ray diffraction
X-ray intensity data were measured at 160 K from single crystals
of 1 and 2 on a Rigaku OD XtaLAB Synergy, Dualex, Pilatus 200
K diffractometer using a single wavelength X-ray source (Cu Ka
radiation: l ¼ 1.54184 Å). Pre-experiment, data collection, data
reduction and analytical absorption correction38 were per-
formed with the program suite CrysAlisPro (Version
1.171.40.39a, Rigaku Oxford Diffraction, 2018).Using Olex2,39
the structure was solved with the SHELXT structure solution
program40 and the structural renement was performed with
the SHELXL 2018/3 program package.41 In 2, the phenyl ring was
disordered over two sets of positions with site-occupancy factors
of 0.501(3) and 0.499(3). For both structures, the position of
amine H atom was located from a difference Fourier map and
rened freely along with its isotropic temperature factors. The
methyl H atoms were constrained to an ideal geometry with
C–H¼ 0.98 Å and Uiso(H)¼ 1.5Ueq(C), but were allowed to rotate
freely about the C–C bond. The remaining H atoms were xed
by a riding model approach with C–H ¼ 0.95–0.99 Å and Uiso(H)
¼ 1.2Ueq(C). PLATON was used to check the result of the X-ray
analysis.42
Details of theoretical calculations
For all the density functional theory (DFT) calculation, the M06-
2X functional43 and cc-pVTZ basis set44 was used with the
incorporation of Grimme's dispersion correction (D3).45 The
geometry optimization carried out using the renedmodels of 1
and 2 (major disordered component) with Gaussian 09
program.46 Further, the optimized structures were subjected to
vibrational frequency calculation in order to conrm the energy
minima on the potential energy surface.
The H involving bond lengths were adjusted to their typical
neutron diffraction values (C–H ¼ 1.083 Å and N–H ¼ 1.009 Å).
Aer resetting the bond lengths, the resultant molecular
geometries were used for the following analysis: (i) qualitative
analysis of intermolecular interactions using Hirshfeld
surface47 and 2D-ngerprint plots48 with the program
CrystalExplorer-17.5 (ref. 49) and (ii) intermolecular interaction
energies (Etot) for dimers of 1 and 2 using PIXELC module of
CLP program package.50–53 The energy frameworks of these two
structures (for 2, the major disordered component was
considered) were performed using CrystalExplorer with B3LYP/
6-31G(d,p) level of theory.54 For the PIXELC calculation, the
electron density for the monomer of 1 and 2 (both major and
minor disordered components) has been obtained separately at
the MP2/6-31G** level of theory using the Gaussian 09 program.
The topological analysis of the intra- and intermolecular
interactions was carried out using AIMALL package.55 For this
calculation, the wave functions were calculated at normalized
crystal structure geometries with M06-2X-D3/cc-pVTZ level of
theory. The dissociation energy (De) for different non-covalent
interactions was obtained by EML formula.56 Various topolog-
ical properties such as r(r), V2r(r), V(r), G(r) and H(r) were
computed for intra and intermolecular interactions at their
bond critical points (BCPs). Further, the wave functions and
cube les were used as input for the molecular electrostatic
potential surfaces of 1 and 2. These surfaces were mapped over
the electron density at 0.001 au using WFA-SAS suite.57
Molecular docking analysis
The 3D structures of dihydrofolate reductase (DHFR) enzyme
from two different species (Homo sapiens; PDB ID: 2W3A and
Staphylococcus aureus; PBD ID: 2W9H) were used in the present
study to investigate the anticancer and antibacterial activities of
the title pyrimidine derivatives utilizing an in silico molecular
docking approach. The docking calculation was performed
using the Schrödinger suite 2019-4 (Schrödinger, LLC, New
York, NY, 2019). For docking calculation, the protein structure
was prepared using the protein prep wizardmodule with default
settings. Similarly, the title compounds and control inhibitor
(trimethoprim) were prepared using the liprep module with
OPLS3e force eld. The grid box was constructed based on the
position of the trimethoprim inhibitor complexed with human
and bacterial enzymes. The glide XP docking58 was performed to
predict the best binding pose and assess inhibitory potential
using docking scores.
Results and discussion
The present work probes the role of two substituents (thiophene
and phenyl moieties) at the 4th position of the pyrimidine ring
on the intermolecular interactions, crystal packing, evaluation
of non-covalent interactions, energy frameworks and inhibitory
potential against DHFR enzyme from human and methicillin
resistant Staphylococcus aureus. Further, a detailed evaluation of
the intermolecular interactions using the QTAIM approach is
presented.
Description of crystal structures of 1 and 2
Single crystal data and renement parameters for 1 and 2 are
presented in Table 1. Compound 1 {systematic name: 2-
(ethylthio)-1,6-dihydro-6-oxo-4-(thiophen-2-yl)pyrimidine-5-carbo
nitrile} crystallizes in themonoclinic systemwith the space group
P21/n. Compound 2 {systematic name: 2-(ethylthio)-1,6-dihydro-
6-oxo-4-phenylpyrimidine-5-carbonitrile} crystallizes in the
triclinic system with the centrosymmetric P1 space group.
Thermal ellipsoidal plots of compounds 1 and 2 are shown in



























































































































Fig. 1. As mentioned in the experimental section, the phenyl ring
of 2 was disordered over two orientations with nearly equal site
occupancy factors. The thioethyl moiety is nearly coplanar with
the pyrimidine ring in both 1 and 2. The dihedral angle formed
between the mean planes of these groups being 7.28 in 1 and
6.37 in 2. It should be noted that the phenyl ring (27.45–28.20
in minor and major disordered components) is more twisted
than the thiophene ring (5.51) with respect to the mean plane of
the pyrimidine ring.
The structural superimposition of X-ray structures of 1 and 2
is given in Fig. 1. As can be seen from Fig. 1, the phenyl ring is
slightly twisted compared to thiophene ring. The optimized
structures of 1 and 2 are in close agreement with their corre-
sponding X-ray structure geometry.
Intramolecular interactions
The molecular conformation of 1 and 2 is stabilized by an
intramolecular C–H/C interaction involving one of the protons
(H11) of the thiophene ring and the C9 atom of cyano group. A
similar intramolecular interaction has also been observed in
many cyano containing organic compounds reported earlier from
our group.59–61 This intramolecular interaction was further
examined in both X-ray and optimized structures using QTAIM
analysis. In the X-ray geometry of 1, the bond path is established
between H and cyano carbon (hence it is a C–H/C interaction)
whereas in the corresponding optimized structure, the bond path
is shied to cyano N from cyano carbon (hence it is a C–H/N
interaction). The molecular graphs showing the intramolecular
interaction in X-ray and optimized structures of 1 and 2 are
depicted in Fig. 2. The topological parameters for these interac-
tions are summarized in Table S1.† From the analysis, we note
that the intramolecular interaction observed in X-ray and opti-
mized structures of 1 and 2 shows van der Waals type nature
(based on KP-4 rule) except C–H/N interaction in the optimized
structure of 1. This intramolecular C–H/N interaction displays
Table 1 Crystal data and refinement parameters for crystals 1 and 2
1 2
Crystal data
Chemical formula C11H9N3OS C13H11N3OS
Mr 263.33 257.31
Crystal system, space group Monoclinic, P21/n Triclinic, P1
Temperature (K) 160 (1) 160 (1)
a, b, c (Å) 14.5546 (2), 4.9907 (5), 17.1813 (3) 4.6908 (2), 9.2376 (3), 14.6613 (3)
a, b, g () 90, 113.268 (2), 90 94.308 (2), 93.766 (2), 100.924 (3)
V (Å3) 1146.50 (12) 619.95 (4)
Z 4 2
Radiation type Cu Ka (l ¼ 1.54184) Cu Ka (l ¼ 1.54184)
m (mm1) 4.10 2.25
rCalc (g cm
3) 1.526 1.378
Crystal size (mm3) 0.09  0.09  0.03 0.13  0.03  0.02
Data collection




Absorption correction Analytical Analytical
Tmin, Tmax 0.745, 0.908 0.848, 0.960
No. of measured, independent
and observed [I > 2s(I)] reections





R[F2 > 2s(F2)], wR(F2), S 0.025, 0.069, 1.06 0.033, 0.089, 1.02
No. of reections 2336 2524
No. of parameters 159 205
H-atom treatment H-atom treated by a mixture of independent
and constrained renement
H-atom treated by a mixture of independent
and constrained renement
Drmax, Drmin (e Å
3) 0.29, 0.23 0.30, 0.31
CCDC no. 2022218 2022219
Fig. 1 ORTEP diagrams of compounds (a) 1, (b) major disordered
component of 2 and (c) minor disordered component of 2 drawn at
the 50% probability level. Atom-numbering scheme is given.



























































































































hydrogen bonding character. Moreover, intramolecular C–H/C
interaction is slightly stronger in the X-ray structure of 2
compared to 1 and the optimized structure of 2. It is of interest to
note that the intramolecular C–H/C interaction is absent as
evident from the topological analysis in related structures in
which aliphatic groups are present at the 2nd position of the
pyrimidine nucleus.28–30
Hirshfeld surface (HS) and 2D-ngerprint plots
In 1, the highly directional N1–H1/O6 hydrogen-bonded dimer
is showing bright red areas on the HS, whereas the intermo-
lecular C7–H72/N2 interaction and S2/S2 (lp/lp) contact are
also visible on the HS with pale red marks. In 2, two intermo-
lecular hydrogen bonding interactions (N1–H1/O6 and C8–
H81/N2) are visible on the HS and large red areas appeared
over the phenyl ring due to disorder. Fig. 3 highlights the short
intermolecular interactions observed in 1 and 2 and these
features suggest that these interactions play an essential role in
the stabilization of crystal structure.
To explain the effect of thiophene and phenyl substituents
on the intermolecular interactions observed in the solid state,
we obtained 2D-ngerprint plots (2D-FP) (Fig. S1†). The result
shows that the intermolecular H/H contacts have a signicant
contribution to both structures. The intermolecular H/N/C/O
interactions provide substantial contributions toward crystal
packing and the relative contributions of these contacts are
comparable in 1 and 2. However, there is a substantial increase
of H/H (16.2%) contacts in 2 compared to 1 due to the pres-
ence of phenyl substituent and its disorder. Further, the inter-
molecular S/C(p) contact described as a chalcogen bond, is
reduced in 2 by 6.6% towards the crystal packing compared to 1.
It is worthy to note that the 3.6% increase of S/S contacts to the
total HS area due to the presence of additional S atom in 1 and
its participation in the intermolecular interaction. The corre-
sponding contact appeared around 3.4 Å in the FP plot and this
contact contributes about 1.0% towards the crystal packing of
a related structure.29
It should be pointed out that the chalcogen bond (S/O)
contributes 1.1% to the total HS area in 1 and the corresponding
interaction is found to be 0.1%. In one of the closely related
structures, the corresponding contact contributes about 1.7% to
the crystal packing.30 The existence of chalcogen and other
intermolecular interactions in 1 and 2 is further evaluated by
QTAIM analysis.
Analysis of molecular electrostatic potential surface
The molecular electrostatic potential surface maps for X-ray and
optimized structures of 1 and 2were generated. The distribution of
electrostatic potentials is very similar in both structures including
their corresponding optimized structures (Fig. 4). However, the
values of positive (Vs,max) and negative (Vs,min) electrostatic poten-
tials are varied. In 1, the most positive electrostatic potential has
occurred at the amine proton of the pyrimidine ring with the Vs,max
value of 53.5 kcal mol1 and at other important protons H72 and
H12 have Vs,max values of 23.2 and 21.4 kcal mol
1, respectively.
The most negative electrostatic potential observed for carbonyl
oxygen (O6; Vs,min:46.3 kcal mol
1) followed cyano nitrogen (N2;
Vs,min: 41.1 kcal mol
1).
It is of interest to note that the pyrimidine N3 atomhas a weak
accepting tendency as evident from the Vs,min value of
5.0 kcal mol1. The sulphur atoms in 1 show distinct features of
electrostatic potentials and the thiophene S2 atom has relatively
more negative electrostatic potential (Vs,min: 2.6 kcal mol
1)
compared to S1 atom (Vs,min: 2.2 kcal mol
1). As mentioned
above, compound 2 possesses similar electrostatic potentials and
the values of Vs,max and Vs,min are comparable in the X-ray
structures of 1 and 2. As shown in Fig. 4, the values of positive
and negative electrostatic potentials vary between X-ray and
optimized structure for some of the donor and acceptors atoms.
This variation is indicating the effect of crystal packing.
Fig. 2 Molecular graphs showing intramolecular interactions in (a) X-
ray structure of 1 (b) optimized structure of 1, (c) X-ray structure of 2
(major disordered component), (d) X-ray structure of 2 (minor disor-
dered component) and (e) optimized structure of 2.
Fig. 3 Short intermolecular interactions visualized using Hirshfeld
surfaces mapped over dnorm for (a) 1 and (b) 2 and (c) the relative
contribution of different intermolecular interactions observed in 1 and
2 (d) the relative contribution of two chalcogen contacts (S/C/O) in
1 and 2.



























































































































Dimers in the crystal structure of 1
The intermolecular interactions energies calculated by the
PIXEL method for dimers of 1 are summarized in Table 2 and
these energies are ranging from 20.9 to 4.3 kcal mol1.
These dimers (Fig. 5 and 6) are stabilized by both classical and
non-classical non-covalent interactions such as N–H/O, C–H/
p, C–H/N, C/C, S/S, S/C and S/O]C interactions. The
latter two non-covalent interactions can be classied as chal-
cogen bonds.
The strong dimer (D1; Etot:20.9 kcal mol
1) forms by a linear
N–H/O hydrogen bond involving amine group (N1–H1) and
carbonyl O6 atom and this hydrogen bond produces a cyclic R2
2(8)
synthon. The contribution of electrostatic energy was calculated to
be 86% towards the stabilization of this cyclic synthon. The dimer
D2 (Etot: 7.6 kcal mol
1) is stabilized by intermolecular C–H/p
(centroid of the pyrimidine ring) and stabilization is further sup-
ported by a weak chalcogen bond S/C(p) contact. This weak
chalcogen bond is established by sum of vdW radii of S and C
atoms +0.03 Å. It should be noted that this dimer is predominantly
dispersive with a contribution of 76%. It is realized that this one of
the rare chalcogen bonds formed between thiophene S and cyano
C atom. To support this statement, a CSD search was performed
using sumof the vdW radii of S and C +0.03 Å cut-off andwe found
that 46 hits contain this contact and the contact distance ranging
from 3.359 to 3.529 Å.
It is to be noted that adjacent D1 dimers are interlinked by
dimer D2 which is further extended along the crystallographic
b axis. Dimer D3 (Etot: 6.0 kcal mol
1) supports by a weak and
long intermolecular C/C (involving C11 and C12) contact. This
contact only appears when the distance being sum of vdW radii of
interacting atoms +0.09 Å. The electrostatic and dispersion ener-
gies contribute 42% and 58%, respectively towards the stabiliza-
tion of this dimer. Moreover, each molecule in this dimer (D3)
interacts with the neighbouring molecule via S/S (involving
thiophene S2 atoms) contact (dimer D6). The intermolecular
Fig. 4 Molecular electrostatic potential of (a) X-ray structure of 1 (left)
and its optimized structure (right) and (b) X-ray structure of major
disordered component of 2 (left) and its optimized structure (right)
mapped over the electron density isosurface at 0.001 au. Colour scale
(in kcal mol1): red: greater than 20; yellow: between 20 and 0; green:
0 to 20 and blue: greater than 20. The important most positive
(Vs,max) and negative (Vs,min) electrostatic potentials are given.
Table 2 Intermolecular interaction energies (in kcal mol1) obtained by the PIXELmethod for variousmolecular pairs observed in the crystals of 1





H/A (Å)/:D–H/A () ECoul Epol Edisp Erep Etot
Compound 1
D1 8.353 x + 1, y, z + 1 N1–H1/O6 1.75/179 29.3 13.9 7.1 29.4 20.9
D2 4.991 x, y  1, z C7–H71/Cg1 2.90/156 2.8 2.4 13.0 10.6 7.6
S2/C9 3.520 (4)
D3 9.058 x + 2, y + 1, z + 1 C11/C12 3.487 (3) 3.0 0.9 5.3 3.2 6.0
D4 10.092 x + 2, y, z + 1 C12–H12/N2 2.63/129 3.8 1.4 3.0 2.7 5.4
D5 7.068 x + 1, y + 1, z + 1 S1/O6]C6 3.683 (4) 2.7 1.5 5.5 4.9 4.9
D6 6.827 x + 3/2, y  1/2, z + 1/2 S2/S2 3.497 (4) 2.2 2.0 9.0 8.5 4.6
D7 9.017 x + 1/2, y + 1/2, z + 1/2 C7–H72/N2 2.57/132 3.2 0.9 2.5 2.3 4.3
Compound 2
D1 8.266 x + 1, y + 1, z + 2 N1–H1/O6 1.72/177 29.2 13.9 6.8 32.8 17.2
D2 10.071 x + 2, y + 1, z + 1 C12A–H121/N2 2.67/121 4.2 1.6 4.6 3.9 6.4
D3 9.535 x  1, y  1, z C8–H83/O6 2.67/131 1.5 0.5 1.9 0.9 3.1
D4 11.853 x  2, y  1, z C8–H81/N2 2.45/161 2.9 0.8 1.3 2.0 3.0
a Neutron values are given for all D–H/A interactions. CD: centroid-to-centroid distance of the molecular pair.
Fig. 5 Different dimers observed in the crystal structure of 1.



























































































































interaction energy for dimer D6 being 4.6 kcal mol1 and the
dispersion energy contributes 68% towards the stabilization of D6.
Intermolecular C–H/N interaction (involving H12 and N2)
stabilizes the dimer D4 (Etot: 5.4 kcal mol
1) with 63% of
electrostatic energy contribution towards the stabilization. This
dimer generates a R2
2(16) motif. Interestingly, another chal-
cogen bond of the type S/O]C (involving S1 and O6) stabilizes
the dimer D5 with an intermolecular interaction energy value of
4.9 kcal mol1. It should be noted that this chalcogen bond is
established only when distance cutoff is relaxed i.e. sum of the
vdW radii of S and O +0.23 Å. The electrostatic and dispersion
energies contribute 43 and 57%, respectively, towards the
stabilization of this dimer. It is also pointed out that dimer D5 is
anked by on both sides by dimer D4. A CSD search identies
this chalcogen bond in 993 structures.
The energetically least dimer D7 (Etot: 4.3 kcal mol
1 with
62% contribution of electrostatic energy towards stabilization)
forms by an intermolecular C–H/N (involving H72 and N2)
interaction. This non-covalent interaction links the molecules
of 1 into a zigzag C(9) chain which runs parallel to the c axis.
Further, dimers D4, D6 and D7 collectively generate two
different closed synthons and these synthons are alternately
arranged in a zigzag manner in the solid state (Fig. 6).
Dimers in the crystal structure of 2
PIXEL energy analysis was carried out for both major andminor
disordered components. For the major component, four
molecular dimers were identied and the intermolecular
interactions for these dimers are ranging from 17.2 to
3.0 kcal mol1 (Table 2). These dimers are stabilized by
intermolecular N–H/O, C–H/O and C–H/N interactions
(Fig. 7). No non-classical contacts including chalcogen bond
exist in this structure.
As observed in 1, the strong dimer (D1; Etot:17.2 kcal mol
1)
stabilizes by an intermolecular N–H/O hydrogen bond with
a cyclic R2
2(8) synthon. The contribution of electrostatic energy
was calculated to be 86% towards the stabilization of this
hydrogen-bonded dimer. Moreover, this dimer is relatively
weaker than dimer D1 in 1 due to the repulsion contribution as
compared to 1. The dimer D2 (Etot: 6.4 kcal mol
1) forms by an
intermolecular C–H/N interaction in which cyano N2 atom
functions as an acceptor, as observed in 1. Though the donor
moiety is different in 1 (thiophene ring) and 2 (phenyl ring),
a cyclic synthon (R2
2(16)) formed by this interaction is the same.
Further, the electrostatic and dispersion energies contribute
about 56 and 44% towards stabilizing D2 dimer in 2. The dimers
D1 and D2 are arranged in an alternate fashion that runs parallel
to the crystallographic c axis (Fig. 7(a)). Unlike in 1, the carbonyl
group is also involved as an acceptor for the intermolecular
C–H/O interaction (dimer D3, Etot: 3.1 kcal mol
1). This
interaction links the molecules into a C(8) chain which runs
parallel to the b axis (Fig. 7(b)). Further, the intermolecular
C–H/N interaction stabilizes the dimer D4 (Etot:
3.0 kcal mol1). The adjacentmolecules of 2 interlinked via this
interaction forms as one-dimensional chain with the graph-set
motif of C(10) which extended along the b axis (Fig. 7(b)). It is
important to emphasize that the contribution of electrostatic
(51%) and dispersion (49%) energies are nearly the same towards
the stabilization of dimer D3. In contrast, dimer D4 is predomi-
nantly electrostatic in nature with the contribution of 74%
towards the stabilization.
As mentioned above, the phenyl ring has participated in an
intermolecular C–H/N (involving C12A–H121 and N2) inter-
action in the major disordered component of 2. The equivalent
atoms are also engaged in an intermolecular C–H/N (involving
C12B–H122 and N2) interaction in the minor disordered part.
The remaining interactions come from the non-disordered
atoms of 2 which are identical with those of interactions
observed in the major disordered component.
Crystal packing and energy frameworks
The crystal packing of 1 can be described as a typical herring-
bone (viewed down a axis) or columnar (viewed down b axis).
Molecules of 2 also packed as a columnar fashion (viewed down
a and b axes). Recently, the energy frameworks have received
considerable attention to understanding the polymorphism,
effect of substituents on the crystal packing and mechanical
properties of the crystals. The 3D topology of the energy
frameworks for crystals 1 and 2 are depicted in Fig. 8. Overall,
Fig. 7 (a) Molecular ribbon formed by motifs D1 and D2 and (b) one-
dimensional molecular chain formed bymotifs D3 andD4 in the crystal
structure of 2.
Fig. 6 Molecular sheets formed by various combinations of motifs in
the crystal structure of 1.



























































































































both electrostatic (red) and total interaction energy (blue) show
similar topology for crystals 1 and 2. The large and small
cylinders are placed alternately in the horizontal layer. In 1, the
large cylinders represent intermolecular N–H/O hydrogen
bond and a weak chalcogen bond (S/O]C). A small cylinders
in each horizontal layer represent intermolecular C–H/N
interaction. The large cylinders in two adjacent layers are
further interconnected by a small cylinder which represents
a weak S/S interaction.
In 2, the large cylinders belong to intermolecular N–H/O
hydrogen bond and a small cylinder which links neighbouring
large cylinders in the horizontal layer represent intermolecular
C–H/N interaction. Although 3D topology of the energy
frameworks looks similar for both 1 and 2, there is a difference
in the large cylinders geometry. In 2, these cylinders are
oriented in a parallel fashion in the same layer and as well as in
the adjacent layers. These features are different in 1 i.e. the large
cylinders are oriented in a parallel fashion in the same layers
and not in the adjacent layers. Desiraju and co-workers inves-
tigated the bending behavior of a large number of structures.
They found that the bending behavior was well correlated with
the shortest crystallographic axis of ca. 4 Å.62 As shown in Fig. 8,
the crystal packing of 1 (b ¼ 4.99 Å) and 2 (a ¼ 4.69 Å) viewed
along the respective shortest crystallographic axis and these
structures showed similar 3D topology of the energy frame-
works. Based on the energy frameworks, one can conclude that
the bending behavior could be similar to 1 and 2.
Analysis of isostructurality
The concept of supramolecular constructs (SC) which are
subcomponents of a complete crystal structure was introduced
by Gelbrich and Hursthouse.63,64 In this study, we used this
concept to identify the similar packing arrangements in the title
compounds and their closely related structures. The common
packing motifs observed in the title compounds and their
closely related structures are depicted in Fig. S2 and S3.† The
structures 1 and 2 show 1D isostructurality (molecular chain)
and the molecular chain has alternate N–H/O and C–H/N
bonded synthons. The structures of 1 and ILEREY display 2D
isostructurality and in both structures respective molecule
forms as layers. These layers are primarily stabilized by N–H/O
and C–H/N interactions. It is important to note that structures
OKUWEY and ZAPQEO share 0D isostructurality (N–H/O
Table 3 Topological parameters for intermolecular interactions in dimers of 1 [values of V(r), G(r) and H(r) are expressed in kJ mol1 bohr3 and
De ¼ 0.5  V(r) in kcal mol
1]
Interaction Rij (Å) r(r) (e Å












N1–H1/O6 1.772 0.281 2.676 108.6 90.8 17.9 1.20 13.0
D2
C7–H71/N1 2.825 0.043 0.517 8.5 11.3 2.8 0.75 1.0
S2/C9 3.614 0.041 0.482 7.5 10.3 2.8 0.73 0.9
D3
C11/C12 3.874 0.034 0.412 5.9 8.5 2.7 0.69 0.7
D4
C12–H12/N2 2.666 0.048 0.631 9.4 13.3 3.9 0.70 1.1
D5
S1/O6]C6 3.571 0.038 0.419 7.1 9.3 2.1 0.77 0.9
D6
S2/S2 3.512 0.055 0.633 11.0 14.1 3.1 0.78 1.3
D7
C7–H72/N2 2.599 0.055 0.704 10.9 15.0 4.1 0.73 1.3
Fig. 8 Energy frameworks for the crystal structures of (a and b) 1 and
(c and d) 2 (major disordered component). The electrostatic (red) and
total interaction energy (blue) components are shown as cylinders.



























































































































mediated dimer) with the structure of 1. The cell parameters of
2 and ILEREY structures are comparable and these two struc-
tures share 3D isostructurality. This 3D isostructurality is
further quantied using isostructurality index (P) proposed by
Fábián and Kálmán65 and theP value is found to be 0.02 for this
pair. Further, structures of 2 and OKUWEY show 0D SC (N–H/
O mediated dimeric pair). However, no supramolecular
construct observed between 2 and ZAPQEO.
Evaluation of intermolecular interactions using QTAIM
analysis
The topological parameters for the non-covalent interactions
observed in structures of 1 and 2 (major disordered compo-
nent) are summarized in Tables 3 and 4. The molecular graphs
exhibiting the non-covalent interactions in these dimers are
illustrated in Fig. S4 and S5.† In 1, there are three intermo-
lecular interactions of the type N–H/O (dimer D1) and
C–H/N (dimers D4 and D7) and all of these interactions
showing hydrogen bonding character according to the KP-4
rule. As mentioned in the previous section, dimer D2 stabi-
lizes with two interactions, namely C7–H71/Cg1(p) and
a chalcogen bond S2/C9. The topological analysis suggests
a bond path that established between H71 and N1 (pyrimidine
ring) atoms resulting in the formation of C–H/N interaction.
This interaction is found to be van der Waals in nature based
on KP-4 rule.
It is of interest to note that the N–H/O hydrogen bond
exposes an intermediate bonding character between shared and
closed-shell interaction as concluded using the following











. 1 and (iii) H(r) < 0. Further,
the remaining hydrogen bonds (C–H/N) belong to closed-shell












and (iii)H(r) > 0. The N–H/O hydrogen bond is calculated to be
strong among other intermolecular interactions in 1 and the
dissociation energy for this hydrogen bond is 13.0 kcal mol1.
The corresponding value for C–H/N hydrogen bonds is in the
range of 1.0–1.3 kcal mol1. As noted earlier, the chalcogen
bonds of the type S/O and S/C interaction are weak in
strength compared to hydrogen bonds and S/S contact and the
dissociation energy for these interactions are the same. We also
noted that the strength of S/S contact is comparable to that of
one of the C–H/N (dimer D7) hydrogen bonds.
In 2 (major disordered component), though all four inter-
molecular (N–H/O, C–H/N and C–H/O type) interactions
showing hydrogen bonding character based on KP-4 rule, one
of the hydrogen bonds (N–H/O) demonstrate intermediate
bonding character between shared and closed-shell interac-
tion as observed in 1. This conclusion has been made based on











. 1 and H(r) < 0. The remaining three hydrogen bonds











\1 and H(r) > 0). The dissociation energy for the
closed-shell interactions is in the range of 1.0–1.6 kcal mol1.
It should be important to note that the N–H/O hydrogen
bond is found be to stronger (De ¼ 14.4 kcal mol
1) compared
to that of the corresponding hydrogen bond in 1. The distri-
bution of Laplacian of electron density and the total electronic
energy density (H(r)) for N–H/O hydrogen bond in 1 and 2 is
Table 4 Topological parameters for intermolecular interactions in dimers of 2 (major disordered component) [values of V(r), G(r) and H(r) are
expressed in kJ mol1 bohr3 and De ¼ 0.5  V(r) in kcal mol
1]
Interaction Rij (Å) r(r) (e Å












N1–H1/O6 1.742 0.301 2.767 120.0 97.7 22.3 1.23 14.4
D2
C12A–H121/N2 2.736 0.046 0.596 9.1 12.7 3.6 0.72 1.1
D4
C8–H83/O4 2.710 0.041 0.513 8.5 11.2 2.7 0.76 1.0
D5
C8–H81/N2 2.476 0.064 0.841 13.3 18.1 4.8 0.74 1.6
Fig. 9 The distribution of the (a and b) Laplacian of the electron
density and (c and d) the total energy density showing the formation of
strong intermolecular N–H/Ohydrogen bond in 1 and 2, respectively.
These diagrams were plotted in the plane comprising the atoms
involved in the hydrogen bond. Small green spheres indicate the bond
critical points.



























































































































depicted in Fig. 9. As can be seen from this gure that the total
electronic energy density (H(r)) has uninterrupted regions of
negative values represent the intermediate bonding character.
Molecular docking
In the present study, we explored the anticancer and antibac-
terial activities of the title compounds against dihydrofolate
reductase (DHFR) enzymes from two different species, namely
Homo sapiens and Staphylococcus aureus, respectively employing
in silico molecular docking approach. The glide XP docking
scores of the title compounds are compared with the control
inhibitors trimethoprim (Table 5). The result suggests that the
glide XP scores for the title compounds are comparable with
trimethoprim for both targets. Both title compounds make at
least one hydrogen bond with the active residue of the DHFR
enzymes. The predicted binding pose of the title compounds at
the active site of the H.s DHFR and S.a DHFR and hydrogen
bond interaction formed between ligand and protein is illus-
trated in Fig. 10. In all cases, either donor or acceptor group of
the pyrimidine moiety has participated in the hydrogen
bonding interaction with the active site residues. Specically,
the amine group in compound 1 is involved in a hydrogen bond
with the backbone carbonyl group of the Val 115 residue of H.s
DHFR. In contrast, the carbonyl group of 1 has participated in
a hydrogen bond with the backbone amine group of Ala 7 of S.a
DHFR enzyme. Similarly, the carbonyl group of 2 makes
a hydrogen bond with the amine group of the conserved Ala 9
residue of H.s DHFR. In contrast, the carbonyl group of 2
involves a hydrogen bond with amine group of conserved Ala 7
of S.a DHFR.
Conclusions
In the present investigation, we explored role of various types of
non-covalent interactions present in the crystal structures of
two pyrimidine-5-carbonitrile derivatives. The X-ray analysis
revealed that the molecular conformation is locked by an
intramolecular C–H/C interaction which is one of the
common interaction observed in nitrile containing organic
compounds. If aliphatic group is present at the 2nd position of
the pyrimidine ring, this intramolecular interaction is not
existing. Both structures 1 and 2 show common 3D topology of
the energy frameworks and these features suggesting that they
have similar bending properties. The molecular electrostatic
potential surface revealed potential sites which are involved in
non-covalent interactions and donating and accepting tenden-
cies of different donor and acceptors sites present in these
compounds. The Hirshfeld surface analysis suggested that the
chalcogen bond is only preferred in thiophene containing
derivative. This result is in good agreement with the PIXEL
energy analysis. This chalcogen bond (formed between thio-
phene S and cyano carbon) is one of the rare non-covalent
interactions as revealed by CSD analysis. The strong dimer in
both compounds formed by highly directional N–H/O
hydrogen bond. The topological analysis indicated that this
hydrogen bond showed intermediate bonding character
between shared and closed-shell interaction. All other interac-
tions observed in both structures are of closed-shell type of
interactions. The common packing motifs observed in the title
compounds and their closely related structures are discussed. A
detailed investigation of molecular docking analysis was per-
formed to probe the inhibitory activities of the title compounds
against DHFR enzyme from two different species (human and
Staphylococcus aureus). The docking results are compared with
known DHFR inhibitor trimethoprim. This in silico docking
analysis suggested that the title compounds have comparable
inhibitory potential against these targets.
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Table 5 The glide XP docking scores (in kcal mol1) for the title
compounds 1 and 2 and control inhibitor
Compound







Trimethoprim (control inhibitor) 6.0 7.3
Fig. 10 Predicted binding poses of the compounds 1 (a and b) and 2 (c
and d) at the active site of (a and c) H.s DHFR (b and d) S.a DHFR.
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